CV Therapeutics
About CV Therapeutics
CV Therapeutics, Inc. is a biopharmaceutical company headquartered in Palo Alto, CA. Focused on the development of novel small molecule therapeutics for the treatment of cardiovascular diseases, CV Therapeutics has emerged as a leader in cardiovascular medicine.
In April 2009, CV Therapeutics was acquired by Gilead Sciences, Inc.
Find CV Therapeutics Execs' Valid Emails
Up to 90% verified emails and mobile numbers, refreshed weekly.
Company Details
25M-75M
Biotechnology Research
201-500 employees
Public Company
Palo Alto, CA
United States
Frequently Asked Questions about
What is CV Therapeutics's industry?
CV Therapeutics operates in the Biotechnology Research industry and is headquartered in United States.
How many employees does CV Therapeutics have?
CV Therapeutics has approximately 201-500 employees employees.
Where is CV Therapeutics's based?
CV Therapeutics is based in Palo Alto, CA, United States.
Is CV Therapeutics publicly listed?
Yes. CV Therapeutics is a publicly traded company.
How can I contact CV Therapeutics's investor relations team?
You can reach CV Therapeutics’s investor relations department through the contact section on their official website or directly via the investor relations email listed in their latest SEC filings.
Find verified emails and phone numbers for professionals like those at
Up to 90% verified emails and mobile numbers, backed by weekly job-change alerts.
Find verified emails at this company
An email pattern tells you the format. It does not tell you who works there now or whether an address still delivers. Scalelist returns verified contacts, checked at the point you build the list.